what remains unclear to us is how UNH will proceed with the contractual obligation of paying for GeneSight as part of its ...
Myriad Genetics earned $4 million from GeneSight testing via UnitedHealthcare in 2024. Myriad reaffirms 2025 EPS guidance of $0.07-$0.11 vs. consensus of $0.06. Get two weeks of free access to pro ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果